97 related articles for article (PubMed ID: 26586794)
1. The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome.
Morten BC; Wong-Brown MW; Scott RJ; Avery-Kiejda KA
Carcinogenesis; 2016 Jan; 37(1):81-86. PubMed ID: 26586794
[TBL] [Abstract][Full Text] [Related]
2. Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcripts.
Perriaud L; Marcel V; Sagne C; Favaudon V; Guédin A; De Rache A; Guetta C; Hamon F; Teulade-Fichou MP; Hainaut P; Mergny JL; Hall J
Carcinogenesis; 2014 Dec; 35(12):2706-15. PubMed ID: 25269805
[TBL] [Abstract][Full Text] [Related]
3. The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer.
Morten BC; Chiu S; Oldmeadow C; Lubinski J; Scott RJ; Avery-Kiejda KA
Breast Cancer Res Treat; 2019 Feb; 173(3):727-733. PubMed ID: 30430302
[TBL] [Abstract][Full Text] [Related]
4. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
5. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years.
Wang-Gohrke S; Becher H; Kreienberg R; Runnebaum IB; Chang-Claude J
Pharmacogenetics; 2002 Apr; 12(3):269-72. PubMed ID: 11927843
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
7. Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion.
Zhang X; Groen K; Morten BC; Steffens Reinhardt L; Campbell HG; Braithwaite AW; Bourdon JC; Avery-Kiejda KA
Mol Oncol; 2022 Jan; 16(2):447-465. PubMed ID: 34657382
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.
Marcel V; Tran PL; Sagne C; Martel-Planche G; Vaslin L; Teulade-Fichou MP; Hall J; Mergny JL; Hainaut P; Van Dyck E
Carcinogenesis; 2011 Mar; 32(3):271-8. PubMed ID: 21112961
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.
Ooe A; Kato K; Noguchi S
Breast Cancer Res Treat; 2007 Mar; 101(3):305-15. PubMed ID: 16821082
[TBL] [Abstract][Full Text] [Related]
10. p53 polymorphisms and haplotypes in breast cancer.
Själander A; Birgander R; Hallmans G; Cajander S; Lenner P; Athlin L; Beckman G; Beckman L
Carcinogenesis; 1996 Jun; 17(6):1313-6. PubMed ID: 8681448
[TBL] [Abstract][Full Text] [Related]
11. The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.
Avery-Kiejda KA; Morten B; Wong-Brown MW; Mathe A; Scott RJ
Carcinogenesis; 2014 Mar; 35(3):586-96. PubMed ID: 24336193
[TBL] [Abstract][Full Text] [Related]
12. Overlapping region of p53/wrap53 transcripts: mutational analysis and sequence similarity with microRNA-4732-5p.
Pouladi N; Kouhsari SM; Feizi MH; Gavgani RR; Azarfam P
Asian Pac J Cancer Prev; 2013; 14(6):3503-7. PubMed ID: 23886136
[TBL] [Abstract][Full Text] [Related]
13. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.
Wang-Gohrke S; Rebbeck TR; Besenfelder W; Kreienberg R; Runnebaum IB
Anticancer Res; 1998; 18(3B):2095-9. PubMed ID: 9677474
[TBL] [Abstract][Full Text] [Related]
14. p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.
Steffens Reinhardt L; Groen K; Zhang X; Morten BC; Wawruszak A; Avery-Kiejda KA
Cell Death Dis; 2023 Aug; 14(8):509. PubMed ID: 37553320
[TBL] [Abstract][Full Text] [Related]
15. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
[TBL] [Abstract][Full Text] [Related]
16. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
[TBL] [Abstract][Full Text] [Related]
17. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma.
Mahasneh AA; Abdel-Hafiz SS
Saudi Med J; 2004 Nov; 25(11):1568-73. PubMed ID: 15573180
[TBL] [Abstract][Full Text] [Related]
19. p53 genotypes and haplotypes associated with risk of breast cancer.
Buyru N; Altinisik J; Demokan S; Dalay N
Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
